Three year anatomic, functional and clinical follow-up after successful percutaneous transluminal coronary angioplasty
DR Rosing,
RO Cannon 3rd,
RM Watson,
RO Bonow,
R Mincemoyer,
C Ewels,
MB Leon,
E Lakatos,
SE Epstein,
and
KM Kent
Because the long-term anatomic effects of percutaneous transluminal coronary angioplasty are unknown, follow-up evaluations including coronary angiography, treadmill exercise testing and rest and bicycle exercise radionuclide angiography were performed in 46 patients 6.3 +/- 2.0 and 37.6 +/- 3.6 (mean +/- SD) months after they had undergone successful single lesion angioplasty. The severity of the coronary stenosis decreased significantly at each evaluation; the mean diameter stenosis was 66 +/- 13% before angioplasty, 30 +/- 13% immediately after and 26 +/- 16% and 19 +/- 13% at 6 months and 3 years, respectively. Exercise time increased from 9.8 +/- 4.4 minutes before angioplasty to 18.3 +/- 4.5 minutes immediately after the procedure and remained at that level at 6 months (20.3 +/- 4.6 minutes) and 3 years (18.2 +/- 4.5 minutes). Left ventricular ejection fraction during exercise decreased 4 +/- 6% compared with rest before angioplasty, but increased 7 +/- 7% immediately after angioplasty and this increase was maintained at 6 months (+/- 6 +/- 7%) and 3 years (+/- 4 +/- 6%). Before angioplasty, 1 patient was in Canadian Heart Association functional class 0, 15 were in class II, 24 in class III and 6 in class IV. Three years later, 25 were in class 0, 10 in class I, 7 in class II and 4 in class III. These results indicate that the short-term anatomic and functional success of coronary angioplasty is maintained for at least 3 years.
This article has been cited by other articles:
|
|
|
|
 
S. Doucet, M. Malekianpour, P. Theroux, L. Bilodeau, G. Cote, Pierre de Guise, J. Dupuis, M. Joyal, G. Gosselin, J.-F. Tanguay, et al.
Randomized Trial Comparing Intravenous Nitroglycerin and Heparin for Treatment of Unstable Angina Secondary to Restenosis After Coronary Artery Angioplasty
Circulation,
March 7, 2000;
101(9):
955 - 961.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Ormiston, F. M. Stewart, A. H. G. Roche, B. J. Webber, R. M. L. Whitlock, and M. W. I. Webster
Late Regression of the Dilated Site After Coronary Angioplasty : A 5-Year Quantitative Angiographic Study
Circulation,
July 15, 1997;
96(2):
468 - 474.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
A. Gurlek, Z. Dagalp, D. Oral, K. Omurlo, C. Erol, T. Akyol, and E. Tutar
Restenosis after Transluminal Coronary Angioplasty: A Risk Factor Analysis
European Journal of Cardiovascular Prevention & Rehabilitation,
February 1, 1995;
2(1):
51 - 55.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. B. Wong, F. A. Sonnenberg, D. N. Salem, and S. G. Pauker
Myocardial Revascularization for Chronic Stable Angina: Analysis of the Role of Percutaneous Transluminal Coronary Angioplasty Based on Data Available in 1989
Ann Intern Med,
December 1, 1990;
113(11):
852 - 871.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C. W. Akins, P. C. Block, I. F. Palacios, H. K. Gold, D. L. Carroll, and G. L. Grunkemeier
Comparison of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty as initial treatment strategies
Ann. Thorac. Surg.,
April 1, 1989;
47(4):
507 - 516.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. J. Popma and G. J. Dehmer
Care of the Patient after Coronary Angioplasty
Ann Intern Med,
April 1, 1989;
110(7):
547 - 559.
[Abstract]
[PDF]
|
|
|
|
